REG - Craneware plc - Bank Refinancing

CranewareAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250901:nRSA3455Xa&default-theme=true

RNS Number : 3455X  Craneware plc  01 September 2025

Craneware plc

("Craneware" or the "Company")

 

 Bank Refinancing

 

1 September 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial
performance solutions, is pleased to announce the successful refinancing of
its banking facilities, providing increased flexibility to execute its growth
strategy, alongside the Group's ongoing strong cash generation and proposed
increase to distributable reserves.

 

The Group has renewed its Revolving Credit Facility ("RCF") on improved terms,
for a further three years, with the option to extend for two further one-year
terms. This new unsecured $100m RCF consolidates the previous term loan and
RCF, is at lower interest rates than the previous facilities, and provides a
further $100m accordion facility that could support potential M&A
activities. The facilities have been provided by a consortium of HSBC,
Barclays, NatWest and Santander.

 

Alongside the Refinancing, the Board has initiated a proposed reduction of
capital, as announced on 1 August 2025. This would create additional
distributable reserves of $284.2m, if ultimately approved by the Court
process, giving the Company further flexibility to deliver shareholder returns
over the coming years, either in the form of distributions and/or purchases of
the Company's own shares. Following the approval of the resolutions to approve
the proposed capital reduction on 20 August 2025, the first court hearing for
initial direction is expected to be held shortly.

 

In July 2025, the Group confirmed it had experienced positive trading
throughout the fiscal year ended 30 June 2025, delivering continued strong
revenue growth, and a double digit increase to profitability, ahead of prior
expectations. The Group continued to deliver high levels of operating cash
conversion, which have been invested in the product portfolio, and reducing
debt, with total bank debt reduced to $27.7m at 30 June 2025 (FY24: $35.4m),
whilst retaining healthy total cash reserves of $55.9m (FY24: $34.6m).

 

The Group will announce audited Final Results for the year ended 30 June 2025
on 15 September 2025.

 

Keith Neilson, CEO of Craneware plc commented, "We would like to thank our
banking partners for their continued support of the business and belief in our
growth strategy. Our strategic position at the heart of the U.S. healthcare
market, strong balance sheet and positive trading provides us with a strong
position from which to explore multiple avenues for growth, as we support our
customers in the transformation of the business of healthcare."

 

 

For further information, please contact:

 

 Craneware plc                                     +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma Strategic Communications (Financial PR)      +44 (0)20 3405 0205
 Caroline Forde, Kinvara Verdon, Sarah Peters      craneware@almastrategic.com

 Peel Hunt (NOMAD and Joint Broker)                +44 (0)20 7418 8900
 Neil Patel, Benjamin Cryer, Kate Bannatyne

 Investec Bank PLC (Joint Broker)                  +44 (0)20 7597 5970
 Patrick Robb, Virginia Bull, James Smith
 ( )                                               ( )
 Berenberg (Joint Broker)                          +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Patrick Dolaghan

 

About The Craneware Group

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus(®) cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth.

 

As a trusted Microsoft partner, we provide future-ready solutions-including
the Best in KLAS Trisus Chargemaster-that simplify the complexities of
healthcare finance and operations. What sets us apart is our unique
combination of deep healthcare expertise and engineering excellence,
positioning us as a strategic partner rather than just a technology provider.

 

The Craneware Group empowers healthcare organizations to achieve sustainable
financial success while delivering better outcomes for the communities they
serve-today and in the future. Together, we are transforming the business of
healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEANPFDAESEFA